Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Research Report, Growth Trends And Competitive Analysis 2022-2028

1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 BA-0702
1.2.3 CDX-3379
1.2.4 Elgemtumab
1.2.5 ETBX-031
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Non-Small Cell Carcinoma
1.3.3 Solid Tumor
1.3.4 Melanoma
1.3.5 Colorectal Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (2017-2028)
2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028)
2.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (2017-2028)
2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Regions (2017-2022)
2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Regions (2017-2022)
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Forecast by Region
2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2023-2028)
2.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2023-2028)
2.4 Global Top Receptor Tyrosine Protein Kinase ERBB 3 Regions (Countries) Ranking by Market Size
2.5 Receptor Tyrosine Protein Kinase ERBB 3 Market Dynamics
2.5.1 Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
2.5.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers
2.5.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
2.5.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers by Sales (2017-2022)
3.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (2017-2022)
3.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Receptor Tyrosine Protein Kinase ERBB 3 Sales in 2021
3.2 Global Top Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 by Revenue
3.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2017-2022)
3.2.2 Top Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Covered: Ranking by Revenue
3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2021)
3.4 Global Receptor Tyrosine Protein Kinase ERBB 3 Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
3.7 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Type (2017-2022)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2022)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2022)
4.1.3 Receptor Tyrosine Protein Kinase ERBB 3 Price by Type (2017-2022)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2023-2028)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Type (2023-2028)
4.2.3 Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Type (2023-2028)
5 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Historic Market Review by Application (2017-2022)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2022)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2022)
5.1.3 Receptor Tyrosine Protein Kinase ERBB 3 Price by Application (2017-2022)
5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2023-2028)
5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Application (2023-2028)
5.2.3 Receptor Tyrosine Protein Kinase ERBB 3 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Company
6.1.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022)
6.1.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022)
6.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
6.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028)
6.2.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2028)
6.3 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
6.3.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028)
6.3.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2028)
6.4 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
6.4.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2028)
6.4.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Company
7.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022)
7.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022)
7.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
7.2.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028)
7.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2028)
7.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
7.3.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028)
7.3.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2028)
7.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
7.4.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2028)
7.4.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Company
8.1.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022)
8.1.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022)
8.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
8.2.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028)
8.2.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2028)
8.3 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
8.3.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028)
8.3.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2028)
8.4 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Region
8.4.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region
8.4.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Company
9.1.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022)
9.1.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022)
9.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
9.2.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028)
9.2.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2028)
9.3 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
9.3.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028)
9.3.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2028)
9.4 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
9.4.1 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2028)
9.4.2 Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Breakdown by Company
10.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022)
10.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022)
10.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Type
10.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2028)
10.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2028)
10.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
10.3.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2028)
10.3.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2028)
10.4 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Country
10.4.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2028)
10.4.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Corporation Information
11.1.2 AstraZeneca Plc Overview
11.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.1.5 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.1.6 AstraZeneca Plc Recent Developments
11.2 AVEO Pharmaceuticals, Inc.
11.2.1 AVEO Pharmaceuticals, Inc. Corporation Information
11.2.2 AVEO Pharmaceuticals, Inc. Overview
11.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.2.5 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.2.6 AVEO Pharmaceuticals, Inc. Recent Developments
11.3 Etubics Corporation
11.3.1 Etubics Corporation Corporation Information
11.3.2 Etubics Corporation Overview
11.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.3.5 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.3.6 Etubics Corporation Recent Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd. Overview
11.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.4.5 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.4.6 F. Hoffmann-La Roche Ltd. Recent Developments
11.5 GamaMabs Pharma S.A.
11.5.1 GamaMabs Pharma S.A. Corporation Information
11.5.2 GamaMabs Pharma S.A. Overview
11.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.5.5 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.5.6 GamaMabs Pharma S.A. Recent Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Corporation Information
11.6.2 GlaxoSmithKline Plc Overview
11.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.6.5 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.6.6 GlaxoSmithKline Plc Recent Developments
11.7 Hanmi Pharmaceuticals, Co. Ltd.
11.7.1 Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
11.7.2 Hanmi Pharmaceuticals, Co. Ltd. Overview
11.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.7.5 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.7.6 Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
11.8 ImmunoGen, Inc.
11.8.1 ImmunoGen, Inc. Corporation Information
11.8.2 ImmunoGen, Inc. Overview
11.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.8.5 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.8.6 ImmunoGen, Inc. Recent Developments
11.9 Kolltan Pharmaceuticals, Inc.
11.9.1 Kolltan Pharmaceuticals, Inc. Corporation Information
11.9.2 Kolltan Pharmaceuticals, Inc. Overview
11.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.9.5 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.9.6 Kolltan Pharmaceuticals, Inc. Recent Developments
11.10 Merrimack Pharmaceuticals, Inc.
11.10.1 Merrimack Pharmaceuticals, Inc. Corporation Information
11.10.2 Merrimack Pharmaceuticals, Inc. Overview
11.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.10.5 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
11.10.6 Merrimack Pharmaceuticals, Inc. Recent Developments
11.11 Merus B.V.
11.11.1 Merus B.V. Corporation Information
11.11.2 Merus B.V. Overview
11.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.11.5 Merus B.V. Recent Developments
11.12 Novartis AG
11.12.1 Novartis AG Corporation Information
11.12.2 Novartis AG Overview
11.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.12.5 Novartis AG Recent Developments
11.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
11.13.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
11.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Overview
11.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments
11.14 Sihuan Pharmaceutical Holdings Group Ltd.
11.14.1 Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
11.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Overview
11.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.14.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
11.15 Sorrento Therapeutics, Inc.
11.15.1 Sorrento Therapeutics, Inc. Corporation Information
11.15.2 Sorrento Therapeutics, Inc. Overview
11.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.15.5 Sorrento Therapeutics, Inc. Recent Developments
11.16 Symphogen A/S
11.16.1 Symphogen A/S Corporation Information
11.16.2 Symphogen A/S Overview
11.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.16.5 Symphogen A/S Recent Developments
11.17 Takis S.r.l.
11.17.1 Takis S.r.l. Corporation Information
11.17.2 Takis S.r.l. Overview
11.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.17.4 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Products and Services
11.17.5 Takis S.r.l. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Receptor Tyrosine Protein Kinase ERBB 3 Value Chain Analysis
12.2 Receptor Tyrosine Protein Kinase ERBB 3 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Receptor Tyrosine Protein Kinase ERBB 3 Production Mode & Process
12.4 Receptor Tyrosine Protein Kinase ERBB 3 Sales and Marketing
12.4.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales Channels
12.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors
12.5 Receptor Tyrosine Protein Kinase ERBB 3 Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of BA-0702
Table 3. Major Manufacturers of CDX-3379
Table 4. Major Manufacturers of Elgemtumab
Table 5. Major Manufacturers of ETBX-031
Table 6. Major Manufacturers of Others
Table 7. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2017-2022)
Table 11. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region (2017-2022)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Receptor Tyrosine Protein Kinase ERBB 3 Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Receptor Tyrosine Protein Kinase ERBB 3 Market Trends
Table 19. Receptor Tyrosine Protein Kinase ERBB 3 Market Drivers
Table 20. Receptor Tyrosine Protein Kinase ERBB 3 Market Challenges
Table 21. Receptor Tyrosine Protein Kinase ERBB 3 Market Restraints
Table 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 23. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers (2017-2022)
Table 24. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers by Revenue (US$ Million) in 2021
Table 26. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2017-2022)
Table 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 3 as of 2021)
Table 29. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Average Selling Price (ASP) & (2017-2022) & (USD/Pcs)
Table 30. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Plants/Factories Distribution
Table 31. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Area Served
Table 32. Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
Table 33. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2017-2022)
Table 36. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2017-2022)
Table 37. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2017-2022)
Table 39. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type (2023-2028)
Table 40. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Type (2023-2028)
Table 41. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2023-2028)
Table 43. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Type (2023-2028)
Table 44. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2017-2022)
Table 45. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2017-2022)
Table 46. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Application (2017-2022)
Table 48. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application (2023-2028)
Table 49. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Application (2023-2028)
Table 50. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2023-2028)
Table 52. Global Receptor Tyrosine Protein Kinase ERBB 3 Price (K Pcs) by Application (2023-2028)
Table 53. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022) & (K Pcs)
Table 54. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2017-2022)
Table 55. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2017-2022)
Table 57. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)
Table 58. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2023-2028) & (K Pcs)
Table 59. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)
Table 62. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2023-2028) & (K Pcs)
Table 63. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)
Table 66. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2023-2028) & (K Pcs)
Table 67. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022) & (K Pcs)
Table 70. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2017-2022)
Table 71. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2017-2022)
Table 73. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)
Table 74. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2023-2028) & (K Pcs)
Table 75. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)
Table 78. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2023-2028) & (K Pcs)
Table 79. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)
Table 82. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2023-2028) & (K Pcs)
Table 83. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022) & (K Pcs)
Table 86. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)
Table 90. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2023-2028) & (K Pcs)
Table 91. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)
Table 94. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2023-2028) & (K Pcs)
Table 95. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2017-2022) & (K Pcs)
Table 98. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales by Region (2023-2028) & (K Pcs)
Table 99. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022) & (K Pcs)
Table 102. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2017-2022)
Table 103. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2017-2022)
Table 105. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)
Table 106. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2023-2028) & (K Pcs)
Table 107. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)
Table 110. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2023-2028) & (K Pcs)
Table 111. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)
Table 114. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2023-2028) & (K Pcs)
Table 115. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Company (2017-2022) & (K Pcs)
Table 118. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2017-2022) & (K Pcs)
Table 122. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type (2023-2028) & (K Pcs)
Table 123. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2017-2022) & (K Pcs)
Table 126. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application (2023-2028) & (K Pcs)
Table 127. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2017-2022) & (K Pcs)
Table 130. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales by Country (2023-2028) & (K Pcs)
Table 131. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Country (2023-2028) & (US$ Million)
Table 133. AstraZeneca Plc Corporation Information
Table 134. AstraZeneca Plc Description and Overview
Table 135. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 136. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 137. AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 138. AstraZeneca Plc Recent Developments
Table 139. AVEO Pharmaceuticals, Inc. Corporation Information
Table 140. AVEO Pharmaceuticals, Inc. Description and Overview
Table 141. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 142. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 143. AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 144. AVEO Pharmaceuticals, Inc. Recent Developments
Table 145. Etubics Corporation Corporation Information
Table 146. Etubics Corporation Description and Overview
Table 147. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 149. Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 150. Etubics Corporation Recent Developments
Table 151. F. Hoffmann-La Roche Ltd. Corporation Information
Table 152. F. Hoffmann-La Roche Ltd. Description and Overview
Table 153. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 154. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 155. F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 156. F. Hoffmann-La Roche Ltd. Recent Developments
Table 157. GamaMabs Pharma S.A. Corporation Information
Table 158. GamaMabs Pharma S.A. Description and Overview
Table 159. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 160. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 161. GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 162. GamaMabs Pharma S.A. Recent Developments
Table 163. GlaxoSmithKline Plc Corporation Information
Table 164. GlaxoSmithKline Plc Description and Overview
Table 165. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 166. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 167. GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 168. GlaxoSmithKline Plc Recent Developments
Table 169. Hanmi Pharmaceuticals, Co. Ltd. Corporation Information
Table 170. Hanmi Pharmaceuticals, Co. Ltd. Description and Overview
Table 171. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 172. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 173. Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 174. Hanmi Pharmaceuticals, Co. Ltd. Recent Developments
Table 175. ImmunoGen, Inc. Corporation Information
Table 176. ImmunoGen, Inc. Description and Overview
Table 177. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 178. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 179. ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 180. ImmunoGen, Inc. Recent Developments
Table 181. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 182. Kolltan Pharmaceuticals, Inc. Description and Overview
Table 183. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 184. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 185. Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 186. Kolltan Pharmaceuticals, Inc. Recent Developments
Table 187. Merrimack Pharmaceuticals, Inc. Corporation Information
Table 188. Merrimack Pharmaceuticals, Inc. Description and Overview
Table 189. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 190. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 191. Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 SWOT Analysis
Table 192. Merrimack Pharmaceuticals, Inc. Recent Developments
Table 193. Merus B.V. Corporation Information
Table 194. Merus B.V. Description and Overview
Table 195. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 196. Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 197. Merus B.V. Recent Developments
Table 198. Novartis AG Corporation Information
Table 199. Novartis AG Description and Overview
Table 200. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 201. Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 202. Novartis AG Recent Developments
Table 203. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 204. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Description and Overview
Table 205. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 206. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 207. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments
Table 208. Sihuan Pharmaceutical Holdings Group Ltd. Corporation Information
Table 209. Sihuan Pharmaceutical Holdings Group Ltd. Description and Overview
Table 210. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 211. Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 212. Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
Table 213. Sorrento Therapeutics, Inc. Corporation Information
Table 214. Sorrento Therapeutics, Inc. Description and Overview
Table 215. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 216. Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 217. Sorrento Therapeutics, Inc. Recent Developments
Table 218. Symphogen A/S Corporation Information
Table 219. Symphogen A/S Description and Overview
Table 220. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 221. Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 222. Symphogen A/S Recent Developments
Table 223. Takis S.r.l. Corporation Information
Table 224. Takis S.r.l. Description and Overview
Table 225. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2017-2022)
Table 226. Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product and Services
Table 227. Takis S.r.l. Recent Developments
Table 228. Key Raw Materials Lists
Table 229. Raw Materials Key Suppliers Lists
Table 230. Receptor Tyrosine Protein Kinase ERBB 3 Distributors List
Table 231. Receptor Tyrosine Protein Kinase ERBB 3 Customers List
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase ERBB 3 Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type in 2021 & 2028
Figure 3. BA-0702 Product Picture
Figure 4. CDX-3379 Product Picture
Figure 5. Elgemtumab Product Picture
Figure 6. ETBX-031 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application in 2021 & 2028
Figure 9. Non-Small Cell Carcinoma Use Case
Figure 10. Solid Tumor Use Case
Figure 11. Melanoma Use Case
Figure 12. Colorectal Cancer Use Case
Figure 13. Others Use Case
Figure 14. Receptor Tyrosine Protein Kinase ERBB 3 Report Years Considered
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size 2017-2028 (US$ Million)
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (2017-2022) & (K Pcs)
Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Market Share by Region: 2021 VS 2028
Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region (2017-2022)
Figure 20. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Region in 2021
Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Region in 2017 VS 2021
Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Manufacturers in 2021
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase ERBB 3 Sales in 2021
Figure 24. Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers in 2021
Figure 25. Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 26. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Type (2017-2022)
Figure 27. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate by Type in 2017 & 2021
Figure 28. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Application (2017-2022)
Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Growth Rate by Application in 2017 & 2021
Figure 30. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2028)
Figure 31. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2028)
Figure 32. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2028)
Figure 33. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2028)
Figure 34. North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country (2017-2028)
Figure 35. North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country (2017-2028)
Figure 36. U.S. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 37. Canada Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 38. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2028)
Figure 39. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2028)
Figure 40. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2028)
Figure 41. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2028)
Figure 42. Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country (2017-2028)
Figure 43. Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country (2017-2028)
Figure 44. Germany Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 45. France Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 46. U.K. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 47. Italy Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 48. Russia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 49. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2028)
Figure 50. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2028)
Figure 51. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2028)
Figure 52. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2028)
Figure 53. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Region (2017-2028)
Figure 54. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Region (2017-2028)
Figure 55. China Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 56. Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 57. South Korea Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 58. India Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 59. Australia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 60. Taiwan Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 61. Indonesia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 62. Thailand Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 63. Malaysia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 64. Philippines Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 65. Vietnam Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2028)
Figure 67. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Application (2017-2028)
Figure 69. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Sales Share by Country (2017-2028)
Figure 71. Latin America Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Country (2017-2028)
Figure 72. Mexico Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Receptor Tyrosine Protein Kinase ERBB 3 Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 3

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.